ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.990
-0.030 (-1.49%)
At close: Aug 13, 2025, 4:00 PM
2.000
+0.010 (0.50%)
Pre-market: Aug 14, 2025, 9:13 AM EDT
Company Description
ImmunoPrecise Antibodies Ltd. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.
It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production.
The company was incorporated in 1983 and is headquartered in Austin, Texas.
ImmunoPrecise Antibodies Ltd.
| Country | United States |
| Founded | 1983 |
| IPO Date | Jan 3, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 102 |
| CEO | Jennifer Bath |
Contact Details
Address: Industrious 823 Congress Ave, Suite 300 Austin, Texas 78701 United States | |
| Phone | 800-620-4187 |
| Website | ipatherapeutics.com |
Stock Details
| Ticker Symbol | IPA |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| CIK Code | 0001715925 |
| CUSIP Number | 45257F200 |
| ISIN Number | CA45257F2008 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jennifer Lynne Bath Ph.D. | Chief Executive Officer, President and Non-Independent Director |
| Joseph Scheffler | Interim Chief Financial Officer |
| Dr. Ilse Roodink | Chief Scientific Officer and Interim General Manager of IPA Europe, Oss |
| Kari Graber | Vice President of Commercial Services |
| Dirk Van Hyfte M.D., Ph.D. | Chief Technology Officer |
| Frederic Chabot | Head of Corporate Development |
| Ingrid Brands M.D., Ph.D. | Chief Innovation and Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 6, 2025 | 6-K | Report of foreign issuer |
| Aug 1, 2025 | 6-K | Report of foreign issuer |
| Jul 29, 2025 | 6-K | Report of foreign issuer |
| Jul 29, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Jul 24, 2025 | 6-K | Report of foreign issuer |
| Jul 21, 2025 | 6-K | Report of foreign issuer |
| Jul 14, 2025 | 6-K | Report of foreign issuer |
| Jul 7, 2025 | 6-K | Report of foreign issuer |
| Jul 3, 2025 | 6-K | Report of foreign issuer |
| Jun 24, 2025 | 6-K | Report of foreign issuer |